1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. Japan >
  6. Shin Nippon Biomedical Laboratories >
  7. M&A

Shin Nippon Biomedical Laboratories Mergers & Acquisitions

Shin Nippon Biomedical Laboratories M&A Summary

Shin Nippon Biomedical Laboratories has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.

Shin Nippon Biomedical Laboratories has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories Ltd.

2438 Miyanoura-cho,
Kagoshima, 891-1394
Japan,
+81 9 9294 3389
www.snbl.co.jp

All (2) Buy (1) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2023-04-17 Satsumarx · Life Science
South San Francisco, California · www.satsumarx.com

Satsumarx is a clinical-stage biopharmaceutical company focused on developing STS101 as an important and differentiated therapeutic option for the acute treatment of migraines. Satsumarx was incorporated in 2016 and is headquartered in South San Francisco, California.

- Add-on Acquisition

Shin Nippon Biomedical Laboratories

-

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal